Press release
Align Technology Announces Second Quarter 2024 Financial Results
Total Invisalign® patients surpasses 18 million globally, including over 5 million teens and kids Q2'24 total revenues of $1,028.5 million, increased 3.1%
About this update from Align Technology, Inc.
[{"type":"text","content":"\nTotal Invisalign® patients surpasses 18 million globally, including over 5 million teens and kids\n\n\n\nQ2'24 total revenues of $1,028.5 million, increased 3.1% sequentially, and increased 2.6% year-over-year, and Q2'24 diluted net income per share was $1.28, or $2.41 on a non-GAAP diluted basis\n\n\n\nQ2'24 total revenues were unfavorably impacted by foreign exchange of approximately $11.6 million or 1.1% sequentially and unfavorably impacted by approximately $18.1 million or 1.7% year-over-year(1)\n\n\n\nQ2'24 Imaging Systems and CAD/CAM Services revenues of $196.8 million, increased 9.2% sequentially, and increased 16.1% year-over-year\n\n\n\nQ2'24 Clear Aligner revenues of $831.7 million, increased 1.8% sequentially, and decreased 0.1% year-over-year\n\n\n\nClear Aligner volume of 642.7 thousand cases increased 6.2% sequentially, and increased 3.2% year-over-year\n\n\n\nQ2'24 Clear Aligner volume for teens increased 8.8% sequentially, and increased 8.0% year-over-year to 216.7 thousand cases\n\n\n\nQ2'24 operating income of $147.0 million and operating margin of 14.3%, non-GAAP operating margin of 22.3%\n\n\n\nQ2'24 GAAP operating margin was unfavorably impacted by foreign exchange of approximately 0.6 points sequentially and unfavorably impacted by approximately 1.2 points year-over-year(1)\n\n\n\n TEMPE, Ariz.--(BUSINESS WIRE)--\nAlign Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today reported financial results for the second quarter (\"Q2'24\"). Q2'24 total revenues were $1,028.5 million, up 3.1% sequentially and up 2.6% year-over-year. Q2'24 total revenues were unfavorably impacted by foreign exchange of approximately $11.6 million or 1.1% sequentially and unfavorably impacted by approximately $18.1 million or 1.7% year-over-year.(1) Q2'24 Clear Aligner revenues were $831.7 million, up 1.8% sequentially and down 0.1% year-over-year. Q2'24 Clear Aligner revenues were unfavorably impacted by foreign exchange of approximately $9.5 million or 1.1% sequentially and unfavorably impacted by approximately $14.7 million or 1.7% year-over-year.(1) Q2'24 Clear Aligner volume was up 6.2% sequentially and up 3.2% year...